283 related articles for article (PubMed ID: 32788219)
1. The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3.
Wedemeyer MJ; Mahn SA; Getschman AE; Crawford KS; Peterson FC; Marchese A; McCorvy JD; Volkman BF
J Biol Chem; 2020 Oct; 295(40):13927-13939. PubMed ID: 32788219
[TBL] [Abstract][Full Text] [Related]
2. Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.
Jaracz-Ros A; Bernadat G; Cutolo P; Gallego C; Gustavsson M; Cecon E; Baleux F; Kufareva I; Handel TM; Bachelerie F; Levoye A
J Leukoc Biol; 2020 Jun; 107(6):1123-1135. PubMed ID: 32374043
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding.
Gustavsson M; Dyer DP; Zhao C; Handel TM
Sci Signal; 2019 Sep; 12(598):. PubMed ID: 31506383
[TBL] [Abstract][Full Text] [Related]
4. Dual targeting of the chemokine receptors CXCR4 and ACKR3 with novel engineered chemokines.
Hanes MS; Salanga CL; Chowdry AB; Comerford I; McColl SR; Kufareva I; Handel TM
J Biol Chem; 2015 Sep; 290(37):22385-97. PubMed ID: 26216880
[TBL] [Abstract][Full Text] [Related]
5. Crosslinking-guided geometry of a complete CXC receptor-chemokine complex and the basis of chemokine subfamily selectivity.
Ngo T; Stephens BS; Gustavsson M; Holden LG; Abagyan R; Handel TM; Kufareva I
PLoS Biol; 2020 Apr; 18(4):e3000656. PubMed ID: 32271748
[TBL] [Abstract][Full Text] [Related]
6. Interaction of chemokine receptor CXCR4 in monomeric and dimeric state with its endogenous ligand CXCL12: coarse-grained simulations identify differences.
Cutolo P; Basdevant N; Bernadat G; Bachelerie F; Ha-Duong T
J Biomol Struct Dyn; 2017 Feb; 35(2):399-412. PubMed ID: 26813575
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation.
Ziarek JJ; Kleist AB; London N; Raveh B; Montpas N; Bonneterre J; St-Onge G; DiCosmo-Ponticello CJ; Koplinski CA; Roy I; Stephens B; Thelen S; Veldkamp CT; Coffman FD; Cohen MC; Dwinell MB; Thelen M; Peterson FC; Heveker N; Volkman BF
Sci Signal; 2017 Mar; 10(471):. PubMed ID: 28325822
[TBL] [Abstract][Full Text] [Related]
8. Development of novel CXC chemokine receptor 7 (CXCR7) ligands: selectivity switch from CXCR4 antagonists with a cyclic pentapeptide scaffold.
Oishi S; Kuroyanagi T; Kubo T; Montpas N; Yoshikawa Y; Misu R; Kobayashi Y; Ohno H; Heveker N; Furuya T; Fujii N
J Med Chem; 2015 Jul; 58(13):5218-25. PubMed ID: 26042340
[TBL] [Abstract][Full Text] [Related]
9. Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3.
Gao X; Abdelkarim H; Albee LJ; Volkman BF; Gaponenko V; Majetschak M
PLoS One; 2018; 13(9):e0204041. PubMed ID: 30248140
[TBL] [Abstract][Full Text] [Related]
10. G protein activation via chemokine (C-X-C motif) receptor 4 and α
Gao X; Majetschak M
FEBS Lett; 2023 Aug; 597(15):2017-2027. PubMed ID: 37395117
[TBL] [Abstract][Full Text] [Related]
11. α
Albee LJ; Eby JM; Tripathi A; LaPorte HM; Gao X; Volkman BF; Gaponenko V; Majetschak M
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862946
[TBL] [Abstract][Full Text] [Related]
12. G protein‑mediated EGFR transactivation is a common mechanism through which the CXCL12 receptors, CXCR4 and CXCR7, control human cancer cell migration.
Zieger-Naumann K; Kuhl F; Engele J
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38099418
[TBL] [Abstract][Full Text] [Related]
13. Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.
Benredjem B; Girard M; Rhainds D; St-Onge G; Heveker N
J Biol Chem; 2017 Jan; 292(1):31-42. PubMed ID: 27875312
[TBL] [Abstract][Full Text] [Related]
14. Atypical Chemokine Receptor 3 "Senses" CXC Chemokine Receptor 4 Activation Through GPCR Kinase Phosphorylation.
Schafer CT; Chen Q; Tesmer JJG; Handel TM
Mol Pharmacol; 2023 Oct; 104(4):174-186. PubMed ID: 37474305
[TBL] [Abstract][Full Text] [Related]
15. Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices.
Wescott MP; Kufareva I; Paes C; Goodman JR; Thaker Y; Puffer BA; Berdougo E; Rucker JB; Handel TM; Doranz BJ
Proc Natl Acad Sci U S A; 2016 Aug; 113(35):9928-33. PubMed ID: 27543332
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists.
Szpakowska M; Meyrath M; Reynders N; Counson M; Hanson J; Steyaert J; Chevigné A
Biochem Pharmacol; 2018 Jul; 153():299-309. PubMed ID: 29530506
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of the interactions between CXCR4 and CXCL12/SDF-1 revealed by theoretical approaches.
Xu L; Li Y; Sun H; Li D; Hou T
Mol Biosyst; 2013 Aug; 9(8):2107-17. PubMed ID: 23702796
[TBL] [Abstract][Full Text] [Related]
18. Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3.
Heuninck J; Perpiñá Viciano C; Işbilir A; Caspar B; Capoferri D; Briddon SJ; Durroux T; Hill SJ; Lohse MJ; Milligan G; Pin JP; Hoffmann C
Mol Pharmacol; 2019 Dec; 96(6):778-793. PubMed ID: 31092552
[TBL] [Abstract][Full Text] [Related]
19. New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle.
Evans AE; Tripathi A; LaPorte HM; Brueggemann LI; Singh AK; Albee LJ; Byron KL; Tarasova NI; Volkman BF; Cho TY; Gaponenko V; Majetschak M
Int J Mol Sci; 2016 Jun; 17(5):. PubMed ID: 27331810
[TBL] [Abstract][Full Text] [Related]
20. Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12.
Del Molino Del Barrio I; Wilkins GC; Meeson A; Ali S; Kirby JA
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30441765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]